Dementia testing specialist boosted with six-figure investment

Vicky Zivkovic
A fast-growing company that specialises in the genetic testing for Alzheimer’s disease has secured a six figure investment to boost its growth plans. Maven Capital Partners, one of the UK’s most active SME finance providers, has invested an undisclosed sum on behalf of NPIF–Maven Equity Finance, part of the Northern Powerhouse Investment Fund (NPIF). Cytox, which has offices in Manchester and Oxford, has a mission to transform how treatments are developed, people are screened and therapies are prescribed for neurological d... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close